NAD+ and Sirtuins in Aging

01 · NAD+ is a currency, not a fountain of youth

Nicotinamide adenine dinucleotide is a coenzyme found in living cells. The oxidized form, NAD+, and reduced form, NADH, shuttle electrons through metabolism. NAD+ is also consumed by enzyme families that respond to cellular stress, including sirtuins and PARPs.

That dual role makes NAD+ biologically interesting: its availability can connect energy state, DNA damage responses, mitochondrial function, and gene regulation. It does not make NAD+ a single master switch for aging.

02 · Sirtuins read the energy state

Sirtuins are NAD+-dependent signaling proteins. In simplified terms, they remove acyl groups from target proteins while using NAD+ as a substrate, producing nicotinamide and other products. SIRT1, SIRT3, and SIRT6 are often discussed in aging research, but their effects depend on tissue, stress state, and experimental model.

03 · Why levels become a research question

NAD+ metabolism is dynamic. Cells synthesize it through de novo, Preiss–Handler, and salvage routes, while CD38 and other enzymes consume it. In aging models, altered synthesis, higher consumption, and inflammation can shift the balance.

The chart’s pathway labels are deliberately not a supplement ranking. A precursor that raises NAD+ in blood or a tissue does not automatically reproduce the effects of exercise, repair, or a sirtuin-targeted intervention.

04 · The supplement leap

Nicotinamide riboside and nicotinamide mononucleotide are among the compounds studied as NAD+ precursors. Animal results helped drive interest, while human trials have generally focused on pharmacokinetics, tolerability, metabolic markers, or specific disease endpoints.

05 · Fasting, exercise, and the network

The video places NAD+, sirtuins, fasting, mTOR, autophagy, and DNA repair in a connected aging network. That is a better mental model than treating any one molecule as an isolated lever. Exercise and energy balance affect many pathways at once, while supplements usually perturb a narrower slice.

Network biology also explains why a “more is better” dose can fail. NAD+ is needed for normal physiology, but changing one node can alter immune signaling, tumor biology, or methylation balance.

06 · The evidence boundary

Research milestones establish mechanisms and testable hypotheses. They do not establish a universal anti-aging protocol. For human translation, investigators still need validated tissue measurements, clinically meaningful endpoints, long follow-up, and a clear account of who benefits or faces risk.

The most responsible claim is therefore conditional: NAD+ metabolism and sirtuins are plausible aging mechanisms, and some interventions are worth testing. Whether they slow human aging remains unsettled.

07 · A better question for the clinic

Instead of asking whether NAD+ “boosters” work in the abstract, ask which NAD+ deficit is being measured, in which tissue, with what assay, and against which outcome. The answer should distinguish a biochemical response from a patient benefit.